ANI Pharmaceuticals, Inc. Reports 62% Rise In Q2 Profit

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) revealed earnings for its second quarter that rose from last year.

The company said its bottom line came in at $12.80 million, or $1.11 per share. This was higher than $7.88 million, or $0.68 per share, in last year's second quarter.

The company said revenue for the quarter rose 60.6% to $31.34 million. This was up from $19.52 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance:

-Earnings (Q2): $12.80 Mln. vs. $7.88 Mln. last year. -Earnings Growth (Y-o-Y): 62.4% -EPS (Q2): $1.11 vs. $0.68 last year. -EPS Growth (Y-o-Y): 63.2% -Revenue (Q2): $31.34 Mln vs. $19.52 Mln last year. -Revenue Change (Y-o-Y): 60.6%

-Guidance: Full year EPS guidance: $4.00 - $4.25 Full year revenue guidance: $119 - $134 Mln